BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chrostek L, Panasiuk A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol 2014; 20(25): 8018-8023 [PMID: 25009372 DOI: 10.3748/wjg.v20.i25.8018]
URL: https://www.wjgnet.com/1948-5182/full/v20/i25/8018.htm
Number Citing Articles
1
Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe. Cirrhosis: Reviewing the Literature and Future PerspectivesEMJ Hepatology 2016; : 111 doi: 10.33590/emj/10310535
2
Paul Carrier, Murielle Girard, Marilyne Debette-Gratien, Natacha Ouedraogo, Véronique Loustaud-Ratti, Philippe Nubukpo. Liver elastometry and alcohol withdrawal: Median-term follow-up in a psychiatric unitAlcohol 2020; 89: 49 doi: 10.1016/j.alcohol.2020.07.007
3
Vladimir Vračarić, Božidar Dejanović, Nebojsa Janjić, Milica Zirojević, Željka Savić, Olgica Latinović Bosnjak, Tihomir Orlić, Žarko Krnetić, Dimitrije Damjanov, Maria Pete, Maja Ružić. Non-invasive Assessment of Liver Damage Degree in Patients with Viral Hepatitis: Is It Feasible and Acceptable?Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-144504
4
Chengxia Xie, Bo Ma, Ning Wang, Lin Wan. Comparison of serological assessments in the diagnosis of liver fibrosis in bile duct ligation miceExperimental Biology and Medicine 2017; 242(14): 1398 doi: 10.1177/1535370217718179
5
Jaime Arellanes-Robledo, Joseph Ibrahim, Karina Reyes-Gordillo, Ruchi Shah, Leslie Leckey, M. Raj Lakshman. Flightless-I is a potential biomarker for the early detection of alcoholic liver diseaseBiochemical Pharmacology 2021; 183: 114323 doi: 10.1016/j.bcp.2020.114323
6
Xiaofeng Liu, Shuzhen Yu, Yao Zhang, Wei Zhang, Hao Zhong, Xiaoqin Lu, Rongfa Guan. A review on the protective effect of active components in Antrodia camphorata against alcoholic liver injuryJournal of Ethnopharmacology 2023; 300: 115740 doi: 10.1016/j.jep.2022.115740
7
Arnaud Chalin, Bruno Turlin, Ahmad Ousmen, Sophie Michalak, Johannes Mueller, Sebastian Mueller, Ludivine Legros, Edouard Bardou‐Jacquet, Jean François Viel, Michel Samson, Romain Moirand. Non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastographyAlimentary Pharmacology & Therapeutics 2023; 58(1): 80 doi: 10.1111/apt.17515
8
Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Annals of Hepatology 2019; 18(3): 518 doi: 10.1016/j.aohep.2019.04.005
9
Koya Fujimoto, Takehiro Shiinoki, Yuki Yuasa, Hidekazu Tanaka. Estimation of liver elasticity using the finite element method and four‐dimensional computed tomography images as a biomarker of liver fibrosisMedical Physics 2021; 48(3): 1286 doi: 10.1002/mp.14723
10
Novriantika Lestari, Melva Louisa, Vivian Soetikno, Averina Geffanie Suwana, Putra Andito Ramadhan, Taufiq Akmal, Wawaimuli Arozal. Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 PathwaysJournal of Toxicology 2018; 2018: 1 doi: 10.1155/2018/5360496
11
Lucas Trevisan França de Lima, Darrell H.G. Crawford, Daniel A. Broszczak, Xi Zhang, Kim Bridle R., Chamindie Punyadeera. A salivary biomarker panel to detect liver cirrhosisiScience 2023; 26(7): 107015 doi: 10.1016/j.isci.2023.107015
12
Qi Wang, Xuefei Dai, Wanzhi Yang, He Wang, Han Zhao, Feng Yang, Yan Yang, Jun Li, Xiongwen Lv. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cellsInternational Immunopharmacology 2015; 25(2): 340 doi: 10.1016/j.intimp.2015.02.012
13
Gary L Norman, Nikolaos K Gatselis, Zakera Shums, Christos Liaskos, Dimitrios P Bogdanos, George K Koukoulis, George N Dalekos. Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(14): 1875-1883 doi: 10.4254/wjh.v7.i14.1875
14
Arantza Sanvisens, Alvaro Muñoz, Ferran Bolao, Paola Zuluaga, Magí Farré, Inmaculada Jarrin, Jordi Tor, Roberto Muga. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?Drug and Alcohol Dependence 2018; 188: 180 doi: 10.1016/j.drugalcdep.2018.04.008
15
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller. Subclinical versus advanced forms of alcohol-related liver disease: Need for early detectionClinical and Molecular Hepatology 2023; 29(1): 1 doi: 10.3350/cmh.2022.0017
16
Chun-Yi Wang, Hsiang-Han Kao, Kuan-Yu Lai, Ching-Chun Lin, Wen-Yuan Lin, Chiu-Shong Liu, Tsung-Po Chen. Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional StudyMetabolites 2022; 12(10): 893 doi: 10.3390/metabo12100893
17
A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin. Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markersRussian Journal of Gastroenterology, Hepatology, Coloproctology 2016; 26(3): 52 doi: 10.22416/1382-4376-2016-26-3-52-63
18
Meritxell Ventura‐Cots, Nambi Ndugga, Ramon Bataller. Evidence‐based Gastroenterology and Hepatology 4e2019; : 503 doi: 10.1002/9781119211419.ch34
19
Yongli Zhou, Yandong Li, Na Wang, Xiuying Li, Jianyun Zheng, Liqiao Ge. UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43148-z
20
Mack C. Mitchell, Gyongyi Szabo. Schiff's Diseases of the Liver2017; : 699 doi: 10.1002/9781119251316.ch26
21
Subramaniam Arulvijayavani, Anbalagan Anithasri, Sivaneshan Harini. COMPARISON OF NON-INVASIVE FIBROSIS SCORES BETWEEN ALCOHOLIC LIVER DISEASE PATIENTS AND HEALTHY NON-ALCOHOLICS IN SOUTH INDIAN POPULATIONJournal of Evidence Based Medicine and Healthcare 2019; 6(31): 2084 doi: 10.18410/jebmh/2019/424
22
Kazuya Kariyama, Kazuhiro Nouso, Hidenori Toyoda, Toshifumi Tada, Atsushi Hiraoka, Kunihiko Tsuji, Ei Itobayashi, Toru Ishikawa, Akiko Wakuta, Ayano Oonishi, Takashi Kumada, Masatoshi Kudo, on behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group, HCC fourtyeight Group. Utility of FIB4-T as a Prognostic Factor for Hepatocellular CarcinomaCancers 2019; 11(2): 203 doi: 10.3390/cancers11020203
23
Tara Morgan, Aliya Qayyum, Richard M. Gore. Textbook of Gastrointestinal Radiology, 2-Volume Set2015; : 1629 doi: 10.1016/B978-1-4557-5117-4.00089-1
24
J Alfredo Martínez, Marta Alonso-Bernáldez, Diego Martínez-Urbistondo, Juan A Vargas-Nuñez, Ana Ramírez de Molina, Alberto Dávalos, Omar Ramos-Lopez. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseasesWorld Journal of Gastroenterology 2022; 28(44): 6230-6248 doi: 10.3748/wjg.v28.i44.6230
25
Cecilia Zertuche-Martínez, Juan Manuel Velázquez-Enríquez, Karina González-García, Rafael Baltiérrez-Hoyos, Gabriela Carrasco-Torres, Rebeca García-Román, Roberto Iván Romero-Díaz, José Luis Pérez-Hernández, Pablo Muriel, Saúl Villa-Treviño, Jaime Arellanes-Robledo, Verónica Rocío Vásquez-Garzón. Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinomaToxicology Mechanisms and Methods 2024; 34(4): 398 doi: 10.1080/15376516.2023.2294475
26
Jose Altamirano, Eric S. Orman, Ramon Bataller. Yamada' s Textbook of Gastroenterology2015; : 2043 doi: 10.1002/9781118512074.ch103
27
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD dietBiomedicine & Pharmacotherapy 2018; 108: 424 doi: 10.1016/j.biopha.2018.06.134
28
Na Duan, Hongxia Chen, Liya Pi, Youssef Ali, Qi Cao. Cis-4-[18F]fluoro-L-proline PET/CT molecular imaging quantifying liver collagenogenesis: No existing fibrotic deposition in experimental advanced-stage alcoholic liver fibrosisFrontiers in Nuclear Medicine 2022; 2 doi: 10.3389/fnume.2022.952943
29
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu. A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLDJournal of Viral Hepatitis 2023; 30(4): 287 doi: 10.1111/jvh.13808
30
Jian Wang, Xiaomin Yan, Li Zhu, Jiacheng Liu, Yuanwang Qiu, Yiguang Li, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Shengxia Yin, Xin Tong, Juan Xia, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zoneAlimentary Pharmacology & Therapeutics 2023; 57(5): 464 doi: 10.1111/apt.17272
31
HIROKI NISHIKAWA, YUKIO OSAKI, HIDEYUKI KOMEKADO, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, AKIRA ARIMOTO, RYUICHI KITA, TORU KIMURA. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resectionOncology Reports 2015; 33(1): 88 doi: 10.3892/or.2014.3573
32
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology 2015; 63(1): 237 doi: 10.1016/j.jhep.2015.04.006
33
Freya A Rhodes, Paul Trembling, Jasmina Panovska‐Griffiths, Sudeep Tanwar, Rachel H Westbrook, Alison Rodger, William M Rosenberg. Systematic review: Investigating the prognostic performance of four non‐invasive tests in alcohol‐related liver diseaseJournal of Gastroenterology and Hepatology 2021; 36(6): 1435 doi: 10.1111/jgh.15335
34
Viola Schlossberger, Mathias Worni, Christina Kihm, Matteo Montani, Christian Datz, Jochen Hampe, Felix Stickel. Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver FibrosisGut and Liver 2019; 13(1): 77 doi: 10.5009/gnl18037
35
Maria Hernandez-Tejero, Ana Clemente-Sanchez, Ramon Bataller. Spectrum, Screening, and Diagnosis of Alcohol-related Liver DiseaseJournal of Clinical and Experimental Hepatology 2023; 13(1): 75 doi: 10.1016/j.jceh.2022.10.002
36
Donogh Maguire, David P. Ross, Dinesh Talwar, Ewan Forrest, Hina Naz Abbasi, John‐Paul Leach, Marylynne Woods, Luke Y. Zhu, Scott Dickson, Tong Kwok, Isla Waterson, George Benson, Benjamin Scally, David Young, Donald C. McMillan. Low serum magnesium and 1‐year mortality in alcohol withdrawal syndromeEuropean Journal of Clinical Investigation 2019; 49(9) doi: 10.1111/eci.13152
37
Arunraj Namachivayam, Abilash Valsala Gopalakrishnan. A review on molecular mechanism of alcoholic liver diseaseLife Sciences 2021; 274: 119328 doi: 10.1016/j.lfs.2021.119328
38
Nora V. Bergasa. Clinical Cases in Hepatology2022; : 255 doi: 10.1007/978-1-4471-4715-2_8
39
Hiroki Nishikawa, Yukio Osaki. Liver Cirrhosis: Evaluation, Nutritional Status, and PrognosisMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/872152
40
Novriantika Lestari, Daniel Amartya, Vivian Soetikno, Melva Louisa. Apoptotic activity of alpha-mangostin in acetaldehyde- induced LX2 hepatic stellate cell linesTHE 4TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, HEALTH, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2019 2019; 2193: 030019 doi: 10.1063/1.5139356
41
Philippe Mathurin, Ramon Bataller. Trends in the management and burden of alcoholic liver diseaseJournal of Hepatology 2015; 62(1): S38 doi: 10.1016/j.jhep.2015.03.006
42
Rosa Lombardi, Elena Buzzetti, Davide Roccarina, Emmanuel A Tsochatzis. Non-invasive assessment of liver fibrosis in patients with alcoholic liver diseaseWorld Journal of Gastroenterology 2015; 21(39): 11044-11052 doi: 10.3748/wjg.v21.i39.11044
43
Z. Gordon Jiang, L. Feldbrügge, E. B. Tapper, Y. Popov, T. Ghaziani, N. Afdhal, S. C. Robson, K. J. Mukamal. Aspirin use is associated with lower indices of liver fibrosis among adults in the United StatesAlimentary Pharmacology & Therapeutics 2016; 43(6): 734 doi: 10.1111/apt.13515
44
Yu Huang, Xiangxue Fan, Ran Tao, Qiqin Song, Likui Wang, Hongyue Zhang, Hongyan Kong, Jiaquan Huang. Effect of miR‐182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathwayJournal of Cellular Physiology 2018; 233(10): 6693 doi: 10.1002/jcp.26469
45
Jorge Soares, António Ferreira, André Silva-Pinto, Francisco Almeida, Carmela Piñeiro, Rosário Serrão, António Sarmento. The Influence of Antiretroviral Therapy on Hepatitis C Virus Viral Load and Liver Fibrosis in Human Immunodeficiency Virus-Coinfected Patients: An Observational StudyIntervirology 2019; 62(5-6): 182 doi: 10.1159/000503631
46
Fengqin Wang, Ying Zhan, Manman Li, Lidan Wang, Austin Zheng, Changbai Liu, Hu Wang, Tao Wang. Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory PathwayACS Pharmacology & Translational Science 2023; 6(1): 76 doi: 10.1021/acsptsci.2c00165
47
Wendi Yu, Maosen Zeng, Peiping Xu, Jinyuan Liu, Huixian Wang. Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of actionPhytomedicine 2021; 92: 153724 doi: 10.1016/j.phymed.2021.153724
48
Onni Niemelä. Advances In Clinical ChemistryAdvances in Clinical Chemistry 2023; 116: 113 doi: 10.1016/bs.acc.2023.05.002